Publikationen in Zusammenarbeit mit Forschern von Hôpital Saint-Louis (4)

2024

  1. Decoding the historical tale: COVID-19 impact on haematological malignancy patients—EPICOVIDEHA insights from 2020 to 2022

    eClinicalMedicine, Vol. 71

2022

  1. Breakthrough COVID-19 in vaccinated patients with hematologic malignancies: results from the EPICOVIDEHA survey

    Blood, Vol. 140, Núm. 26, pp. 2773-2787

2016

  1. European phase II study of mogamulizumab, an anti-CCR4 monoclonal antibody, in relapsed/refractory peripheral T-cell lymphoma

    Haematologica

2013

  1. Multicenter phase II study of plitidepsin in patients with relapsed/refractory non-Hodgkin's lymphoma

    Haematologica, Vol. 98, Núm. 3, pp. 357-363